🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

393,17 USD

Máx. histórico

447,03

14 días

Split 2:1 del 22/11/1999

Caída desde máximo

-12,05%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-10,08%

Cierre anterior

437,23

Rango de hoy

391,17 – 410,03

Volumen hoy

6.589.429

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
24,44 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 5 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,53%
Fecha de pago Importe por participación
14/02/2019 1,4500 USD
15/11/2018 1,3200 USD
16/08/2018 1,3200 USD
16/05/2018 1,3200 USD
14/02/2018 1,3200 USD
16/11/2017 1,1500 USD
15/08/2017 1,1500 USD
15/05/2017 1,1500 USD
13/02/2017 1,1500 USD
14/11/2016 1,0000 USD
15/08/2016 1,0000 USD
13/05/2016 1,0000 USD
11/02/2016 1,0000 USD
12/11/2015 0,7900 USD
13/08/2015 0,7900 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/06/2003 65,92 66,00 63,25 63,38 -3,15% 4,17% 13.282.600
05/06/2003 64,50 65,60 64,00 65,44 +1,47% 2,48% 9.964.100
04/06/2003 63,59 64,50 63,40 64,49 +0,67% 1,73% 7.946.000
03/06/2003 63,37 64,20 63,00 64,06 +0,80% 1,89% 8.095.400
02/06/2003 65,04 65,70 63,05 63,55 -1,84% 4,07% 14.334.300
30/05/2003 63,74 64,90 63,60 64,74 +2,24% 2,04% 8.447.000
29/05/2003 63,70 64,89 62,90 63,32 -0,67% 3,12% 11.032.400
28/05/2003 63,80 64,00 63,20 63,75 +0,16% 1,25% 8.478.000
27/05/2003 61,70 64,00 61,51 63,65 +3,01% 4,04% 16.391.400
23/05/2003 61,86 62,25 61,11 61,79 -0,13% 1,84% 6.353.400
22/05/2003 60,53 62,56 60,47 61,87 +1,94% 3,45% 9.372.000
21/05/2003 60,16 61,13 59,89 60,69 -0,56% 2,06% 9.549.000
20/05/2003 60,42 61,10 60,26 61,03 +1,26% 1,39% 10.698.500
19/05/2003 62,88 63,12 59,96 60,27 -3,27% 5,03% 15.420.800
16/05/2003 62,72 63,25 62,19 62,31 -0,51% 1,69% 6.678.300
15/05/2003 62,05 62,87 61,86 62,63 +1,26% 1,63% 6.646.600
14/05/2003 61,99 62,09 61,30 61,85 +0,57% 1,27% 7.317.900
13/05/2003 61,89 62,47 61,49 61,50 -0,79% 1,58% 7.464.900
12/05/2003 61,24 62,33 60,74 61,99 +1,22% 2,60% 8.477.900
09/05/2003 60,59 61,45 60,14 61,24 +1,27% 2,16% 9.580.700
08/05/2003 59,38 60,97 59,35 60,47 +1,54% 2,73% 11.983.100
07/05/2003 60,66 60,80 59,43 59,55 -2,33% 2,26% 22.727.300
06/05/2003 62,38 62,47 60,36 60,97 -2,77% 3,38% 18.566.200
05/05/2003 63,05 63,99 62,71 62,71 -0,89% 2,03% 8.096.500
02/05/2003 62,27 63,62 62,01 63,27 +1,18% 2,59% 9.404.300
01/05/2003 61,27 62,66 61,17 62,53 +2,01% 2,43% 10.515.500
30/04/2003 61,78 62,25 61,25 61,30 -1,29% 1,62% 12.026.900
29/04/2003 62,91 63,36 61,50 62,10 -1,26% 2,96% 12.892.100
28/04/2003 62,61 63,82 62,45 62,89 -0,17% 2,19% 8.890.800
25/04/2003 63,76 63,95 62,99 63,00 -1,55% 1,51% 9.100.000